{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:51:43Z","timestamp":1768978303372,"version":"3.49.0"},"reference-count":31,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T00:00:00Z","timestamp":1674864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background: Anti-inflammatory corticosteroids are used in cancer treatment and COVID-19 infections. Data on the impact of non-dexamethasone corticosteroids on COVID-19 infection severity in cancer patients are minimal. This study investigates if corticosteroid treatment affects the disease severity in adult cancer patients. Methods: A total of 116 COVID-19-infected cancer patients on hydrocortisone (H) or prednisone (P) were compared to 343 untreated patients. The study included patients who received corticosteroids before (B), after (A), or both before and after (B and A) COVID-19 infections. Ventilation support, hospitalization and mortality were investigated. Results: Our data showed that a significantly greater number of patients taking H or P required ventilation support and hospitalization and that mortality rates were higher than the control group. Patients who received H or P after COVID-19 infection had a significantly worse prognosis than the other sub-groups and the control group. Conclusion: Corticosteroids impacted cancer patients\u2019 COVID-19 prognosis. Despite the limited sample size, H- and P-treated patients\u2019 corticosteroids performed worse than the control, especially if treatments were received after COVID-19 infection. Hence, when a cancer patient already on H or P treatment is diagnosed with COVID-19, we recommend switching to a steroid treatment as suggested by international guidelines.<\/jats:p>","DOI":"10.3390\/vaccines11020290","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T05:57:23Z","timestamp":1675058243000},"page":"290","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Non-Dexamethasone Corticosteroid Therapy\u2019s Effect on COVID-19 Prognosis in Cancer Patients: A Retrospective Study"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3310-8857","authenticated-orcid":false,"given":"Lina","family":"Souan","sequence":"first","affiliation":[{"name":"Department of Pathology & Laboratory Medicine, King Hussein Cancer Center, Amman 11941, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zienab","family":"Al-Khairy","sequence":"additional","affiliation":[{"name":"Department of Pathology & Laboratory Medicine, King Hussein Cancer Center, Amman 11941, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6312-5447","authenticated-orcid":false,"given":"Abdelkader","family":"Battah","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman 11942, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9185-9616","authenticated-orcid":false,"given":"Maher A.","family":"Sughayer","sequence":"additional","affiliation":[{"name":"Department of Pathology & Laboratory Medicine, King Hussein Cancer Center, Amman 11941, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1177\/01945998211064275","article-title":"Corticosteroid Use in Otolaryngology: Current Considerations During the COVID-19 Era","volume":"167","author":"Chang","year":"2022","journal-title":"Otolaryngol. Neck Surg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/400_2008_20","article-title":"Glucocorticoid-Mediated Apoptosis Resistance of Solid Tumors","volume":"49","author":"Herr","year":"2009","journal-title":"Death Recept. Cogn. Ligands Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/978-1-4939-2895-8_14","article-title":"Glucocorticoids and Cancer","volume":"872","author":"Pufall","year":"2015","journal-title":"Glucocorticoid Signal."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000520791","article-title":"Splenic Micronodular T-Cell\/Histiocyte-Rich Large B-Cell Lymphoma: The Corticosteroid Pretreatment Hypothesis","volume":"145","author":"Samueli","year":"2021","journal-title":"Acta Haematol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"103826","DOI":"10.1016\/j.critrevonc.2022.103826","article-title":"Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)\/Italian Association of Medical Dia-betologists (AMD)\/Italian Society of Endocrinology (SIE)\/Italian Society of Pharmacology (SIF) multidisciplinary con-sensus position paper","volume":"180","author":"Faggiano","year":"2022","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejca.2020.09.032","article-title":"How to manage patients with corticosteroids in oncology in the era of immunotherapy?","volume":"141","author":"Aldea","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s11916-010-0120-z","article-title":"Musculoskeletal Pain Associated With Corticosteroid Therapy in Cancer","volume":"14","author":"Frieze","year":"2010","journal-title":"Curr. Pain Headache Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1200\/JCO.1999.17.8.2506","article-title":"Hydrocortisone With or Without Mitoxantrone in Men With Hormone-Refractory Prostate Cancer: Results of the Cancer and Leukemia Group B 9182 Study","volume":"17","author":"Kantoff","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1172\/JCI140617","article-title":"Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome","volume":"130","author":"Liu","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43088-021-00165-0","article-title":"Corticosteroids for treatment of COVID-19: Effect, evidence, expectation and extent","volume":"10","author":"Patel","year":"2021","journal-title":"Beni-Suef Univ. J. Basic Appl. Sci."},{"key":"ref_11","first-page":"Cd014963","article-title":"Systemic corticosteroids for the treatment of COVID-19","volume":"8","author":"Wagner","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in Hospitalized Patients with COVID-19","volume":"384","author":"Group","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1172\/JCI143331","article-title":"Corticosteroids, COVID-19 pneumonia, and acute respiratory distress syndrome","volume":"130","author":"Matthay","year":"2020","journal-title":"J. Clin Investig."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2020.17023","article-title":"Association Between Administration of Systemic Corticosteroids and Mortality among Critically Ill Patients with COVID-19: A Meta-analysis","volume":"324","author":"Sterne","year":"2020","journal-title":"JAMA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.2020.17021","article-title":"Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial","volume":"324","author":"Tomazini","year":"2020","journal-title":"JAMA"},{"key":"ref_16","first-page":"11","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak\u2014An update on the status","volume":"7","author":"Guo","year":"2020","journal-title":"Mil. Med. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-84137-5","article-title":"Oncologic immunomodulatory agents in patients with cancer and COVID-19","volume":"11","author":"Jee","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0040-1712785","article-title":"Ongoing COVID-19 global crisis and scientific challenges","volume":"10","author":"Karunasagar","year":"2020","journal-title":"J. Health Allied Sci. NU"},{"key":"ref_19","first-page":"1","article-title":"The increasing importance of the novel Coronavirus","volume":"49","author":"Mungroo","year":"2020","journal-title":"Hosp. Pr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"107247","DOI":"10.1016\/j.intimp.2020.107247","article-title":"COVID-19 and cancer: From basic mechanisms to vaccine devel-opment using nanotechnology","volume":"90","author":"Han","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00253-020-11061-5","article-title":"Detection technologies and recent developments in the diagnosis of COVID-19 infection","volume":"105","author":"Rai","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"CT406","DOI":"10.1158\/1538-7445.AM2020-CT406","article-title":"Abstract CT406: Patients with cancer appear more vulnerable to SARS-COV-2: A multi-center study during the COVID-19 outbreak","volume":"80","author":"Dai","year":"2020","journal-title":"Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(20)31187-9","article-title":"Clinical impact of COVID-19 on patients with cancer (CCC19): A cohort study","volume":"395","author":"Kuderer","year":"2020","journal-title":"Lancet"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/S0140-6736(20)31173-9","article-title":"COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: A prospective cohort study","volume":"395","author":"Lee","year":"2020","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1158\/2159-8290.CD-20-0516","article-title":"Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System","volume":"10","author":"Mehta","year":"2020","journal-title":"Cancer Discov."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S1470-2045(20)30310-7","article-title":"Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: A multicentre, retrospective, cohort study","volume":"21","author":"Yang","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Souan, L., Al-Khairy, Z., Al-Binni, M.A., Battah, A., and Sughayer, M.A. (2022). The Effect of Dexamethasone Treatment on COVID-19 Prognosis in Cancer Patients. Vaccines, 10.","DOI":"10.3390\/vaccines10111798"},{"key":"ref_28","unstructured":"Team, R.C. (2020). R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.2020.17022","article-title":"Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial","volume":"324","author":"Angus","year":"2020","journal-title":"JAMA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in Hospitalized Patients with Covid-19-Preliminary Report","volume":"384","author":"Horby","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e001019","DOI":"10.1136\/jitc-2020-001019","article-title":"Early changes in immune cell subsets with corticosteroids in patients with solid tumors: Implications for COVID-19 management","volume":"8","author":"Toney","year":"2020","journal-title":"J. Immunother. Cancer"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/2\/290\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:18:14Z","timestamp":1760120294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/2\/290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,28]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["vaccines11020290"],"URL":"https:\/\/doi.org\/10.3390\/vaccines11020290","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,28]]}}}